Episurf's Board to Propose Transaction Approval at Extraordinary General Meeting
The Board of Directors of Episurf Medical AB has resolved to propose the approval of a transaction to an Extraordinary General Meeting, related to Ilija Batljan Invest AB's bond repurchase offer.
Episurf Medical AB's Board of Directors has decided to propose the approval of a transaction for an Extraordinary General Meeting. This decision follows a press release from Ilija Batljan Invest AB (IBI) indicating its intention to repurchase all issued bonds bearing the ISIN SE0015161810.
The offer from IBI aims to buy back all outstanding bonds for a cash payment equivalent to 100 percent of the nominal amount, plus accrued and unpaid interest as per the bond terms. The offer's execution is contingent upon a sufficient number of bondholders accepting it.
Episurf's specific role in this transaction is not detailed in the announcement. However, the board's resolution to put the matter before an Extraordinary General Meeting suggests the company has a significant involvement or obligation related to the arrangement, requiring shareholder approval.
The transaction is part of IBI's financial arrangements. Episurf Medical is a Swedish medical technology company focused on treatments for musculoskeletal conditions.